Periop Nursing

Latest Issue of OR Manager
November 2024
Home Periop Nursing

Clinical outcomes, costs of robotic vs open ventral hernia repair

Editor's Note This study led by researchers at Good Samaritan Medical Center, Brockton, Massachusetts, and Tufts University School of Medicine, Boston, examines the clinical outcomes and costs of robotic and open ventral hernia repairs. A total of 675 open and 609 robotic ventral hernia repairs were included in the analysis.…

Read More

By: Judy Mathias
August 1, 2023
Share

US News & World Report releases Best Hospitals Honor Roll

Editor's Note The US News & World Report, on August 1, released its 2023-2024 Best Hospitals Honor Roll. Just 22 hospitals out of nearly 5,000 evaluated for the Best Hospitals rankings and ratings made the Honor Roll, which examines hospitals in more than 30 medical and surgical services. In alphabetical…

Read More

By: Judy Mathias
August 1, 2023
Share

FDA: Class I recall of Baxter SIGMA Spectrum, Spectrum IQ infusion pumps

Editor's Note The Food and Drug Administration (FDA), on August 1, identified the recall by Baxter Healthcare Corporation of its SIGMA Spectrum Infusion Pump with Master Drug Library (Version 8) and Spectrum IQ Infusion System with Dose IQ Safety Software (Version 9) as Class I, the most serious. The recall…

Read More

By: Judy Mathias
August 1, 2023
Share

Costs of frailty after major, elective noncardiac surgery

Editor's Note This Canadian study finds a 1.5-fold increase in costs in the year after major, elective noncardiac surgery for patients with preoperative frailty. A total of 171,576 patients (23,219 with preoperative frailty) were included in the analysis. Unadjusted costs were higher for frail patients. After adjusting for confounders, an…

Read More

By: Judy Mathias
July 31, 2023
Share

Sponsored Message

Update of strategies to prevent MRSA transmission, infection in acute care hospitals

Editor's Note This expert guidance document, sponsored by the Society for Healthcare Epidemiology of America (SHEA), updates the “Strategies to Prevent Methicillin-Resistant Staphylococcus aureus [MRSA] Transmission and Infection in Acute Care Hospitals” that were published in 2014. Among the updates: Recommendations are now categorized as Essential Practices that should be…

Read More

By: Judy Mathias
July 31, 2023
Share

FDA: Class I recall of GE HealthCare’s TruSignal SpO2 sensors

Editor's Note The Food and Drug Administration (FDA), on July 28, identified the recall by GE HealthCare of its TruSignal SpO2 [arterial oxygen saturation] sensors as Class I, the most serious. The recall was initiated because of issues that may reduce the amount of energy sent to the heart during…

Read More

By: Judy Mathias
July 31, 2023
Share

Sponsored Message

University of Tennessee, Baptist Memorial Health Care pilot OR Scholars program

Editor's Note The University of Tennessee Health Science Center’s (UTHSC) College of Nursing announced a collaboration with Baptist Memorial Health Care to pilot an Operating Room Scholars program to address the perioperative nursing shortage on July 27. “The program will fill a critical need and has the potential to create…

Read More

By: Lindsay Botts
July 27, 2023
Share

Medical confidentiality breaches on Twitter by anesthesiology, intensive care HCWs

Editor's Note This French study examines the rate of medical confidentiality breaches in tweets by anesthesiology and intensive care healthcare workers (HCWs). Data from 431 tweets with photographs and 9,000 text-only tweets from 1,831 accounts were included in the analysis. Among the findings: There were 44 (10.2%) breaches of medical…

Read More

By: Judy Mathias
July 27, 2023
Share

FDA: Class I recall of Abiomed Impella Left Sided Blood Pumps

Editor's Note The Food and Drug Administration (FDA), on July 27, identified the recall by Abiomed of all Impella Left Sided Blood Pumps as Class I, the most serious. Abiomed is recalling the pumps because the instructions for use do not adequately address precautions to take when treating transcatheter aortic…

Read More

By: Judy Mathias
July 27, 2023
Share

FDA: Class I recall of Abbott Amplatzer Steerable Delivery Sheath

Editor's Note The Food and Drug Administration (FDA), on July 26, identified the recall by Abbott of its Amplatzer Steerable Delivery Sheath as Class I, the most serious. Abbott is recalling the sheath because of an increased risk for air emboli being introduced into patients who have cardiac catheterization procedures…

Read More

By: Judy Mathias
July 27, 2023
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat